Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 8;12(7):e062400.
doi: 10.1136/bmjopen-2022-062400.

Vaginal progesterone as luteal phase support in natural cycle frozen-thawed embryo transfer (ProFET): protocol for a multicentre, open-label, randomised controlled trial

Caroline Stadelmann  1   2 , Christina Bergh  3   2 , Mats Brännström  3   2 , Kristbjörg Heiður Olsen  4 , Ali Khatibi  3   2 , Margareta Kitlinski  5 , Susanne Liffner  6 , Eva Lundborg  7 , Kenny A Rodriguez-Wallberg  8   9 , Annika Strandell  3   2 , Göran Westlander  10 , Gabriella Widlund  11 , Åsa Magnusson  3   2
Affiliations

Vaginal progesterone as luteal phase support in natural cycle frozen-thawed embryo transfer (ProFET): protocol for a multicentre, open-label, randomised controlled trial

Caroline Stadelmann et al. BMJ Open. .

Abstract

Introduction: Vaginal progesterone supplementation is frequently given to patients receiving frozen embryo transfer (FET) in the natural cycle aiming to increase the chance of pregnancy and live birth. To date, only a few studies have investigated if progesterone supplementation is beneficial in these cycles and the level of evidence for progesterone supplementation is very low.

Methods and analysis: The ProFET trial is a multicentre, open-label, randomised controlled trial powered for this investigation, including 1800 women with regular menstrual cycles (24-35 days), aged 18-43 years planned for natural cycle-FET receiving a single blastocyst for transfer. Participants are randomised (1:1:1) to either luteal phase progesterone for 3 weeks, luteal phase progesterone for 7 weeks or no luteal phase progesterone. The participating study centres consist of 12 in vitro fertilisation-clinics in Sweden and 1 in Iceland. The primary outcome is to investigate if luteal phase support (LPS) by vaginal progesterone increases the chance of a live birth per randomised patient in a natural FET cycle compared with no LPS.

Ethics and dissemination: The trial was approved by the Swedish Ethical Review Authority (ID 2020-06774, 2021-02822 and 2022-01502-02) and the Swedish Medical Products Agency (ID nr 5.1-2020-102613). All participants are required to provide written informed consent. The outcome of this study will be disseminated to the public through broadcasts, newspapers and presentations at scientific congresses as well as publications in international scientific journals.

Trial registration number: NCT04725864.

Keywords: GYNAECOLOGY; Reproductive medicine; Subfertility.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CB and ÅM declare support from Ferring Pharmaceuticals, Merck Sereno and Gedeon Richter. MB has 4 % stocks in EUGIN Sweden. None of the other authors hade conflicts of interest.

Figures

Figure 1
Figure 1
ProFET trial flow chart. FET, Frozen embryo transfer; LH, luteinising hormone; NC-FET, natural cycle frozen embryo transfer.
See this image and copyright information in PMC

References

    1. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention . Assisted reproductive Technolology, fertility clinic and national summary report 2019. Available: https://www.cdc.gov/art/reports/2019/pdf/2019-Report-ART-Fertility-Clini... [Accessed 16 Feb 2022].
    1. European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Wyns C, De Geyter C, et al. Art in Europe, 2017: results generated from European registries by ESHRE. Hum Reprod Open 2021;2021:hoab026. 10.1093/hropen/hoab026 - DOI - PMC - PubMed
    1. Nationellt kvalitetsregister för assisterad befruktning . Fertility treatments in Sweden national report 2021. Available: https://www.medscinet.com/qivf/uploads/hemsida/Årsrapport%202021%20-%20E... [Accessed 16 Feb 2022].
    1. Balaban B, Urman B, Ata B, et al. A randomized controlled study of human day 3 embryo cryopreservation by slow freezing or vitrification: vitrification is associated with higher survival, metabolism and blastocyst formation. Human Reproduction 2008;23:1976–82. 10.1093/humrep/den222 - DOI - PubMed
    1. Rienzi L, Gracia C, Maggiulli R, et al. Oocyte, embryo and blastocyst cryopreservation in art: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update 2017;23:139–55. 10.1093/humupd/dmw038 - DOI - PMC - PubMed

Publication types

Associated data